The scientist’s investigation covers issues in Neuroscience, Dopamine, Glutamate receptor, Neurotransmitter and Neurotransmission. He combines topics linked to Neurotensin with his work on Neuroscience. His Dopamine study incorporates themes from Neuropeptide, Disease and Substance abuse.
The study incorporates disciplines such as Neurotrophic factors, Dopaminergic and Axon in addition to Glutamate receptor. His Neurotransmitter research incorporates elements of Non-spiking neuron, Monoamine neurotransmitter and Glutamatergic. His Neurotransmission study combines topics from a wide range of disciplines, such as Protein kinase A, GABAergic, Inhibitory postsynaptic potential, gamma-Aminobutyric acid and Cell biology.
Louis-Eric Trudeau focuses on Neuroscience, Dopamine, Dopaminergic, Glutamate receptor and Cell biology. His Neuroscience research includes themes of Glutamatergic and Neurotransmission. His research investigates the connection with Neurotransmission and areas like Biophysics which intersect with concerns in Electrophysiology.
His research investigates the connection between Dopamine and topics such as Neuron that intersect with issues in Endocrinology, Internal medicine and Midbrain. Louis-Eric Trudeau combines subjects such as Synaptic vesicle, Biochemistry and Voltage-dependent calcium channel with his study of Cell biology. The various areas that Louis-Eric Trudeau examines in his Neurotransmitter study include Acetylcholine and Cellular neuroscience.
Louis-Eric Trudeau spends much of his time researching Dopamine, Neuroscience, Substantia nigra, Ventral tegmental area and Dopaminergic. His Dopamine research is multidisciplinary, incorporating elements of SYT7, Addiction and Neurotransmission. Louis-Eric Trudeau focuses mostly in the field of Neuroscience, narrowing it down to matters related to Glutamate receptor and, in some cases, Neurotransmitter.
His study in Substantia nigra is interdisciplinary in nature, drawing from both Striatum, Neurotoxin and Neurodegeneration. His research integrates issues of Parkin, MPTP and Cell biology in his study of Neurotoxin. His Ventral tegmental area research is multidisciplinary, relying on both Ventral striatum and Neuron.
His main research concerns Dopamine, Neuroscience, Substantia nigra, Pars compacta and PINK1. His research in Dopamine intersects with topics in Glutamate receptor, Cholinergic and Neurotransmitter. The concepts of his Neuroscience study are interwoven with issues in Monoamine neurotransmitter, Vesicular transport protein and Neurodegeneration.
The Neurodegeneration study which covers Autophagy that intersects with Dopaminergic. His Pars compacta study integrates concerns from other disciplines, such as Dopamine receptor, Dopamine receptor D2, Axon and Neurotransmission. Louis-Eric Trudeau usually deals with PINK1 and limits it to topics linked to Mitochondrion and Neurotoxin, PARK7, LRRK2 and Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
β-Lactamase protein fragment complementation assays as in vivo and in vitro sensors of protein-protein interactions
André Galarneau;Martin Primeau;Louis-Eric Trudeau;Stephen W. Michnick.
Nature Biotechnology (2002)
From glutamate co-release to vesicular synergy: vesicular glutamate transporters
Salah El Mestikawy;Åsa Wallén-Mackenzie;Guillaume M. Fortin;Laurent Descarries.
Nature Reviews Neuroscience (2011)
Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons.
Consiglia Pacelli;Nicolas Giguère;Marie Josée Bourque;Martin Lévesque.
Current Biology (2015)
Parkinson’s Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation
Diana Matheoud;Ayumu Sugiura;Angélique Bellemare-Pelletier;Annie Laplante.
Direct modulation of the secretory machinery underlies PKA-dependent synaptic facilitation in hippocampal neurons.
Louis-Eric Trudeau;Dennis G Emery;Philip G Haydon.
The role of neurotensin in central nervous system pathophysiology: what is the evidence?
Fannie St-Gelais;Claudia Jomphe;Louis-Éric Trudeau.
Journal of Psychiatry & Neuroscience (2006)
GDNF enhances the synaptic efficacy of dopaminergic neurons in culture.
Marie-Josée Bourque;Louis-Eric Trudeau.
European Journal of Neuroscience (2000)
Intestinal infection triggers Parkinson’s disease-like symptoms in Pink1 −/− mice
Diana Matheoud;Tyler Cannon;Aurore Voisin;Anna-Maija Penttinen.
Dopamine neurons in culture express VGLUT2 explaining their capacity to release glutamate at synapses in addition to dopamine
Gregory Dal Bo;Fannie St-Gelais;Marc Danik;Sylvain Williams.
Journal of Neurochemistry (2004)
Chondroitin sulfate inhibits the nuclear translocation of nuclear factor-κB in interleukin-1β-stimulated chondrocytes
Claudia Jomphe;Mélanie Gabriac;Taben M. Hale;Lucie Héroux.
Basic & Clinical Pharmacology & Toxicology (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: